Cha Hollywood Medical Center, LP

Cha Hollywood Medical Center, LP was paid $15.18M by Medicaid between Jan 2018 and Nov 2024, across 301 billing codes. Its largest line is 0450, Emergency room services — 16% of everything it billed.

33Billing provider infoCHA HOLLYWOOD MEDICAL CENTER, LP
LOS ANGELES, CA 90027

33aNPI1922033547assigned 07/12/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$15.18M

24GClaims779,607

24DCodes billed301

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#145 of 410

Median peer was paid$6.90M

This provider vs. median2.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	139,135	$2.47M
2019	113,834	$2.51M
2020	84,935	$1.64M
2021	98,662	$2.08M
2022	109,822	$2.33M
2023	129,164	$2.55M
2024incomplete	104,055	$1.58M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
0450	Emergency room services	16%	62,962	56,656	$2.39M
70450	Computed tomography, head or brain; without contrast material	4.6%	8,643	8,386	$691K
74176	Computed tomography, abdomen and pelvis; without contrast material	4.3%	8,705	8,455	$655K
Z7502		4.2%	16,859	16,592	$635K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.9%	2,859	2,745	$434K
99281	Emergency department visit for the evaluation and management, self-limited or minor	2.8%	7,455	6,717	$421K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.6%	10,634	10,178	$394K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	2.2%	20,586	19,402	$340K
80053	Comprehensive metabolic panel	2.1%	47,404	43,467	$319K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.1%	6,524	5,835	$315K
S3620	Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)	1.9%	2,072	2,068	$292K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.9%	56,239	50,779	$289K

289 more codes

76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	1.9%	5,273	$284K
96375	Therapeutic injection; each additional sequential IV push	1.8%	10,975	$278K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.8%	5,894	$270K
Z9725		1.7%	8,464	$254K
74177	Computed tomography, abdomen and pelvis; with contrast material	1.5%	1,670	$229K
99199	Unlisted special service, procedure or report	1.5%	6,190	$224K
0206		1.4%	629	$216K
0370		1.4%	4,334	$212K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.4%	4,863	$211K
96361	Intravenous infusion, hydration; each additional hour	1.3%	7,949	$204K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	1.3%	10,045	$202K
72125	Computed tomography, cervical spine; without contrast material	1.3%	1,946	$196K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.2%	11,165	$184K
99284	Emergency room visit (serious)	1.1%	2,419	$169K
71045	Radiologic examination, chest; single view	1.1%	18,973	$168K
0171	Inj, epinephrine (belcher)	1.1%	479	$166K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,914	$148K
0761		<1%	5,253	$141K
0762		<1%	3,397	$127K
0301		<1%	4,985	$127K
0710		<1%	9,593	$120K
99283	Emergency room visit (moderate)	<1%	2,244	$119K
72131		<1%	1,235	$117K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	2,554	$106K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	2,507	$97K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,159	$96K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	11,717	$94K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	3,977	$89K
59025	Fetal non-stress test	<1%	4,172	$83K
J7030	Infusion, normal saline solution , 1000 cc	<1%	11,042	$83K
0121		<1%	499	$81K
84484		<1%	13,161	$80K
0270		<1%	9,639	$74K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	2,044	$74K
70486		<1%	813	$74K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,722	$72K
J3490	Unclassified drugs	<1%	6,073	$69K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	9,733	$67K
93970		<1%	568	$65K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,676	$64K
83690		<1%	14,207	$61K
71250		<1%	595	$59K
81025		<1%	14,139	$59K
0160		<1%	2,716	$56K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	9,445	$55K
93971		<1%	864	$54K
81001		<1%	26,862	$53K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	3,934	$51K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	523	$50K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	2,135	$49K
0122		<1%	189	$44K
90715		<1%	1,607	$43K
83880		<1%	2,943	$43K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	5,935	$41K
0111		<1%	41	$41K
Z7610		<1%	2,615	$39K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	6,524	$38K
0360		<1%	2,294	$34K
0002A		<1%	1,032	$33K
84702		<1%	4,042	$32K
73562		<1%	1,958	$32K
71046	Radiologic examination, chest; 2 views	<1%	2,088	$31K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,761	$31K
0001A		<1%	1,113	$29K
80048	Basic metabolic panel (calcium, ionized)	<1%	8,097	$29K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,915	$29K
73630		<1%	1,652	$29K
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	5,758	$29K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	613	$28K
72110		<1%	1,026	$28K
85730		<1%	9,171	$27K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,001	$27K
73130		<1%	1,428	$26K
73030		<1%	1,736	$26K
94760		<1%	4,393	$24K
73610		<1%	1,275	$24K
82378		<1%	1,351	$23K
0760		<1%	986	$23K
85610		<1%	11,311	$22K
71275	Computed tomographic angiography, chest, with contrast material	<1%	175	$21K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	95	$20K
99215	Doctor's office visit, returning patient (complex)	<1%	275	$20K
84703		<1%	5,647	$20K
93307		<1%	268	$18K
0112		<1%	40	$18K
L8699	Prosthetic implant, not otherwise specified	<1%	18	$18K
86906		<1%	4,571	$17K
87086	Culture, bacterial; quantitative colony count, urine	<1%	4,368	$17K
J1170	Injection, hydromorphone, up to 4 mg	<1%	3,098	$16K
86850		<1%	4,500	$15K
86300		<1%	1,066	$15K
84443	Thyroid stimulating hormone (TSH)	<1%	2,464	$15K
99000		<1%	4,993	$15K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	4,650	$15K
J2060	Injection, lorazepam, 2 mg	<1%	2,774	$14K
88312		<1%	722	$14K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	2,319	$14K
85027		<1%	3,443	$13K
59425		<1%	512	$13K
94761		<1%	563	$13K
87040		<1%	1,603	$12K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	2,605	$12K
80179		<1%	1,176	$12K
80143		<1%	1,191	$12K
J0690	Injection, cefazolin sodium, 500 mg	<1%	3,119	$12K
0272		<1%	2,491	$12K
82948		<1%	5,790	$11K
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	1,178	$11K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	215	$11K
73110		<1%	532	$11K
83605		<1%	1,741	$11K
Z7500		<1%	297	$10K
99221		<1%	264	$10K
76380		<1%	89	$10K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	347	$10K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	523	$9K
82150		<1%	2,187	$8K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	464	$8K
H1001	Prenatal care, at-risk enhanced service; antepartum management	<1%	810	$8K
76641		<1%	151	$8K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	12	$8K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	655	$8K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	554	$8K
0250		<1%	5,363	$7K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	1,512	$7K
Z9727		<1%	218	$7K
80061	Lipid panel	<1%	2,076	$6K
96368		<1%	534	$6K
92083		<1%	632	$6K
96376		<1%	1,436	$6K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,693	$5K
73590		<1%	364	$5K
87186		<1%	1,065	$5K
J7050	Infusion, normal saline solution, 250 cc	<1%	1,362	$5K
92133		<1%	574	$4K
87077		<1%	1,178	$4K
92250		<1%	267	$4K
88342		<1%	206	$4K
0258		<1%	2,994	$4K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	205	$4K
J2704	Injection, propofol, 10 mg	<1%	614	$4K
92134		<1%	450	$4K
93017		<1%	93	$4K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,234	$4K
70496		<1%	40	$4K
85379		<1%	589	$3K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	762	$3K
36415	Collection of venous blood by venipuncture	<1%	3,593	$3K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	693	$3K
82607		<1%	279	$3K
83615		<1%	790	$3K
76512		<1%	85	$3K
0636		<1%	2,917	$3K
73565		<1%	292	$3K
82728		<1%	308	$3K
72170		<1%	191	$3K
73564		<1%	156	$3K
70498		<1%	27	$3K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	231	$3K
84145		<1%	296	$3K
85651		<1%	1,132	$3K
73080		<1%	157	$3K
85007		<1%	1,167	$3K
82746		<1%	204	$3K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,283	$2K
88304		<1%	723	$2K
Z1034		<1%	35	$2K
J1644	Injection, heparin sodium, per 1000 units	<1%	358	$2K
86140		<1%	740	$2K
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	155	$2K
83735		<1%	1,123	$2K
82248		<1%	366	$2K
87070		<1%	365	$2K
A9270	Non-covered item or service	<1%	596	$2K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	302	$2K
76818		<1%	106	$2K
81002		<1%	1,628	$2K
J3590	Unclassified biologics	<1%	479	$2K
82553		<1%	293	$2K
G0378	Hospital observation service, per hour	<1%	35	$2K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	707	$2K
72050		<1%	64	$2K
83550		<1%	312	$2K
87490		<1%	118	$2K
0320		<1%	1,122	$1K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	481	$1K
73700		<1%	13	$1K
84153		<1%	146	$1K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	215	$1K
0637		<1%	1,056	$1K
76819	Fetal biophysical profile; without non-stress testing	<1%	58	$1K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	47	$1K
82232		<1%	125	$1K
10060		<1%	26	$1K
76870		<1%	38	$977.37
76770		<1%	27	$974.38
87205		<1%	364	$965.60
73090		<1%	57	$951.32
59070		<1%	16	$935.00
82550		<1%	273	$925.08
J2358	Injection, olanzapine, long-acting, 1 mg	<1%	94	$845.57
0721		<1%	265	$789.66
96367		<1%	26	$787.25
76510		<1%	32	$783.47
73502		<1%	77	$780.32
80076		<1%	418	$734.89
A4649	Surgical supply; miscellaneous	<1%	946	$694.96
A9150	Non-prescription drugs	<1%	1,041	$694.95
86480		<1%	33	$660.45
99204	Doctor's office visit, new patient (more involved)	<1%	12	$642.09
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	195	$609.32
J1630	Injection, haloperidol, up to 5 mg	<1%	144	$590.15
82247		<1%	386	$522.86
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	112	$519.60
99201		<1%	78	$498.74
0306		<1%	1,960	$492.94
85008		<1%	488	$489.37
76937		<1%	92	$472.27
85018		<1%	469	$434.12
72100		<1%	14	$428.29
71010		<1%	27	$421.89
85044		<1%	112	$414.28
95816		<1%	17	$402.21
J3370	Injection, vancomycin hcl, 500 mg	<1%	98	$377.66
82668		<1%	38	$346.77
84436		<1%	125	$339.33
99213	Doctor's office visit, returning patient (routine)	<1%	14	$319.67
81003		<1%	297	$318.63
74018		<1%	27	$300.84
97161		<1%	80	$292.01
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	56	$286.21
99214	Doctor's office visit, returning patient (more involved)	<1%	12	$276.31
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	287	$254.57
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	38	$187.60
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	44	$186.98
J3360	Injection, diazepam, up to 5 mg	<1%	12	$179.83
86304		<1%	27	$174.20
84550		<1%	194	$172.49
84100		<1%	376	$162.44
86038		<1%	41	$152.44
99153	Mod sedat endo service >5yrs	<1%	38	$151.25
87650		<1%	14	$148.38
J1956	Injection, levofloxacin, 250 mg	<1%	24	$147.36
J3475	Injection, magnesium sulfate, per 500 mg	<1%	16	$141.07
99152		<1%	29	$139.48
A9505	Thallium tl-201 thallous chloride, diagnostic, per millicurie	<1%	12	$132.90
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	37	$111.88
92025		<1%	16	$73.46
C1769	Guide wire	<1%	28	$69.00
76514		<1%	25	$67.52
86780		<1%	14	$63.84
83655		<1%	13	$60.75
J0456	Injection, azithromycin, 500 mg	<1%	23	$50.39
J1815	Injection, insulin, per 5 units	<1%	34	$33.51
88302		<1%	13	$19.76
J1940	Injection, furosemide, up to 20 mg	<1%	23	$17.97
87075		<1%	15	$11.40
0300		<1%	3,124	$9.98
0305		<1%	2,638	$6.75
0730		0%	774	$0.00
0402		0%	434	$0.00
0302		0%	1,786	$0.00
0390		0%	83	$0.00
0921		0%	146	$0.00
96379		0%	130	$0.00
0424		0%	318	$0.00
0480		0%	343	$0.00
0260		0%	26	$0.00
H1000	Prenatal care, at-risk assessment	0%	15	$0.00
0278		0%	110	$0.00
0430		0%	12	$0.00
0460		0%	13	$0.00
0481		0%	15	$0.00
0120		0%	12	$0.00
84439		0%	14	$0.00
0352		0%	130	$0.00
0310		0%	269	$0.00
0410		0%	163	$0.00
0307		0%	484	$0.00
0350		0%	279	$0.00
0420		0%	323	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	17	$0.00
S9445	Patient education, not otherwise classified, non-physician provider, individual, per session	0%	30	$0.00
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	0%	114	$0.00
0257		0%	12	$0.00
97535	Self-care/home management training, each 15 minutes	0%	15	$0.00
0614		0%	27	$0.00
0391		0%	13	$0.00
0771		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRIVERS, KENNETH (PRESIDENT, CEO)